Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$9.17 - $14.8 $426,496 - $688,348
-46,510 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$8.92 - $13.29 $143,701 - $214,101
-16,110 Reduced 25.73%
46,510 $525,000
Q3 2020

Nov 16, 2020

SELL
$9.94 - $16.59 $35,485 - $59,226
-3,570 Reduced 5.39%
62,620 $670,000
Q2 2020

Aug 07, 2020

SELL
$12.07 - $19.34 $132,166 - $211,773
-10,950 Reduced 14.19%
66,190 $1.01 Million
Q4 2019

Feb 14, 2020

SELL
$11.42 - $22.19 $88,048 - $171,084
-7,710 Reduced 9.09%
77,140 $1.6 Million
Q2 2019

Aug 14, 2019

BUY
$18.35 - $30.34 $1.56 Million - $2.57 Million
84,850 New
84,850 $1.66 Million

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Hhr Asset Management, LLC Portfolio

Follow Hhr Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhr Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hhr Asset Management, LLC with notifications on news.